Lymphokine-activated killer cells in primary immunodeficiencies and acquired immunodeficiency syndrome
- 1 December 1989
- journal article
- research article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 53 (3) , 449-459
- https://doi.org/10.1016/0090-1229(89)90007-x
Abstract
No abstract availableThis publication has 37 references indexed in Scilit:
- Enhanced interferon production and lymphokine-activated cytotoxicity of human placental cellsCellular Immunology, 1988
- Cytotoxic studies in human newborns: Lessened allogeneic cell-induced (augmented) cytotoxicity but strong lymphokine-activated cytotoxicity of cord mononuclear cellsCellular Immunology, 1986
- Phenotypic and cytotoxic characteristics of the immune cells of the human placentaCellular Immunology, 1986
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985
- BONE MARROW TRANSPLANTATION FOR WISKOTT-ALDRICH SYNDROME REPORT OF 2 CASES WITH USE OF 2-MERCAPTOETHANE SULFONATETransplantation, 1985
- Generation of nonspecific murine cytotoxic T cells in vitro by purified human interleukin 2Cellular Immunology, 1984
- Severe combined immunodeficiencies, primary T-cell defects and DiGeorge syndrome in humans: Characterization by monoclonal antibodies and natural killer cell activityClinical Immunology and Immunopathology, 1983
- Deficient Lymphokine Production of Newborn LymphocytesPediatric Research, 1983
- Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.The Journal of Experimental Medicine, 1982
- Natural killer and killer cell activities in patients with primary immunodeficiencies or defects in immune interferon productionEuropean Journal of Immunology, 1980